1. Home
  2. AQST vs FFC Comparison

AQST vs FFC Comparison

Compare AQST & FFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$3.92

Market Cap

707.6M

Sector

Health Care

ML Signal

HOLD

Logo Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

FFC

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

HOLD

Current Price

$16.51

Market Cap

796.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQST
FFC
Founded
2004
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
707.6M
796.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
AQST
FFC
Price
$3.92
$16.51
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$8.83
N/A
AVG Volume (30 Days)
4.3M
164.1K
Earning Date
11-05-2025
01-01-0001
Dividend Yield
N/A
6.79%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,397,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$52.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.12
$11.90
52 Week High
$7.55
$14.96

Technical Indicators

Market Signals
Indicator
AQST
FFC
Relative Strength Index (RSI) 22.22 49.28
Support Level $5.86 $16.46
Resistance Level $6.59 $16.62
Average True Range (ATR) 0.32 0.13
MACD -0.13 0.00
Stochastic Oscillator 11.98 42.33

Price Performance

Historical Comparison
AQST
FFC

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.

Share on Social Networks: